LeonaBio, Inc.

LONA Nasdaq SEC CIK 1620463
Follow LeonaBio Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$21.2M −220.1% vs same quarter last year
EPS, diluted −$0.89 +47% vs same quarter last year
Operating cash flow −$18.9M −304.8% vs same quarter last year
Operating income −$21.5M −212.3% vs same quarter last year
Net income by quarter
−$15.1M
−$9.1M
−$7M
−$6.6M
−$83.3M
−$32.9M
−$19M
−$21.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$106M
FY24−$97M
FY23−$117.7M
FY22−$95.6M
FY21−$54.9M
FY20−$20M
FY19−$5.2M
FY18-
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$97.2M
FY23−$101.1M
FY22−$73.6M
FY21−$44.7M
FY20−$26.4M
FY19-
FY18-